£121.73

Springer Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)

Price data checked 2 days ago

View at Amazon

Price History & Forecast

Last 4 days • 4 data points

Historical
Generating forecast...
£121.75 £121.73 £121.73 £121.74 £121.74 £121.75 £121.75 01 May 2026 01 May 2026 02 May 2026 03 May 2026 04 May 2026

Price Distribution

Price distribution over 4 days • 1 price levels

Days at Price
4 days 0 1 2 3 4 £122 Days at Price

Price Analysis

Most common price: £122 (4 days, 100.0%)

Price range: £122 - £122

Price levels: 1 different prices over 4 days

Description

Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary toxic treatment while selecting drugs active in vitro or in the mouse model that might increase the probability of response in the patient. None of these test models, however, achieved routine clinical application in the past. This might be at least in part - lated to large discrepancies that were described between the s- cess rate of the assay systems and the clinical benefit in cancer - tients. The heterogeneity of chemosensitivity that exists between different tumors as well as between individual tumor lesions may be one explanation for these findings. Furthermore, different assay end points such as proliferation, metabolism, and vitality were - veloped to evaluate the effects of cytostatic drugs on tumor cells, and these might be related to the differing results. However, knowledge about procedures for assay-assisted treatment selection has increased rapidly within the past few years, and several studies suggest that test-directed chemotherapy selection now may - prove response rates and survival in various types of tumors. The International Society for Chemosensitivity Testing in - cology (ISCO) was founded to promote, coordinate, and improve clinical and laboratory research in the field of predictive drug te- ing in human tumor cells.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
08 October 2012
Listed Since
06 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Cell Signaling & Molecular Targets in Cancer
77% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Quantum Chemistry Methods for Oncological Drugs
76% match

Quantum Chemistry Methods for Oncological Drugs

Elsevier

£133.05 04 May 2026
Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)
76% match

Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)

Springer

£73.10 04 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
76% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.29 04 May 2026
Precision Medicine in Oncology
76% match

Precision Medicine in Oncology

Wiley-Blackwell

£132.63 04 May 2026
Cancer II: 28 (Topics in Medicinal Chemistry, 28)
76% match

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Springer

£199.19 04 May 2026
Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)
75% match

Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

Springer

£137.00 04 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
75% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
75% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 04 May 2026
Retinoids in Oncology (ESO Monographs)
74% match

Retinoids in Oncology (ESO Monographs)

Springer

£113.93 04 May 2026
Cell Signaling & Molecular Targets in Cancer
74% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Protease Inhibitors as Cancer Chemopreventive Agents
74% match

Protease Inhibitors as Cancer Chemopreventive Agents

Springer

£79.15 04 May 2026
Teaching and Learning Oncology Communication: A Cross-Disciplinary Perspectives in Chinese Context
73% match

Teaching and Learning Oncology Communication: A Cross-Disciplinary Perspectives in Chinese Context

Springer

£85.64 04 May 2026
Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates
73% match

Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates

Springer

£141.86 04 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
73% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
73% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Problem Based Learning Discussions in Onco-Anesthesia and Onco-Critical Care
73% match

Problem Based Learning Discussions in Onco-Anesthesia and Onco-Critical Care

Springer

£92.77 04 May 2026
Experimental and Applied Immunotherapy
73% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
73% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.64 04 May 2026
Koss's Cytology of the Urinary Tract with Histopathologic Correlations
73% match

Koss's Cytology of the Urinary Tract with Histopathologic Correlations

Springer

£93.49 04 May 2026
Application of Apoptosis to Cancer Treatment
73% match

Application of Apoptosis to Cancer Treatment

Springer

£94.37 04 May 2026
Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
73% match

Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects

Springer

£147.11 04 May 2026
Neuroendocrine and Oral Cancers: An Interdisciplinary Approach: 14 (Interdisciplinary Cancer Research, 14)
73% match

Neuroendocrine and Oral Cancers: An Interdisciplinary Approach: 14 (Interdisciplinary Cancer Research, 14)

Springer

£141.08 04 May 2026
Pediatric Oncology: A Comprehensive Guide
73% match

Pediatric Oncology: A Comprehensive Guide

Springer

£64.80 04 May 2026